Global Live Attenuated Polio Vaccine Market Research Report 2024

Live Attenuated Polio Vaccine Market

The global Live Attenuated Polio Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Live Attenuated Polio Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Live Attenuated Polio Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Live Attenuated Polio Vaccine include Sanofi Pasteur, GlaxoSmithKline Bio, Bilthoven Bio, Bharat Biotech and Sinovac Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Live Attenuated Polio Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Polio Vaccine.

Report Scope

The Live Attenuated Polio Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Live Attenuated Polio Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Live Attenuated Polio Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Sanofi Pasteur

GlaxoSmithKline Bio

Bilthoven Bio

Bharat Biotech

Sinovac Biotech

Live Attenuated Vaccine

Inactivated Vaccine

Hospital

Clinic

Health Center

Others

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Scope of Live Attenuated Polio Vaccine Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Live Attenuated Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Live Attenuated Polio Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

1.1 Product Overview and Scope of Live Attenuated Polio Vaccine

1.2 Live Attenuated Polio Vaccine Segment by Type

1.2.1 Global Live Attenuated Polio Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Live Attenuated Vaccine

1.2.3 Inactivated Vaccine

1.3 Live Attenuated Polio Vaccine Segment by Application

1.3.1 Global Live Attenuated Polio Vaccine Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Health Center

1.3.5 Others

1.4 Global Live Attenuated Polio Vaccine Market Size Estimates and Forecasts

1.4.1 Global Live Attenuated Polio Vaccine Revenue 2019-2030

1.4.2 Global Live Attenuated Polio Vaccine Sales 2019-2030

1.4.3 Global Live Attenuated Polio Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2.1 Global Live Attenuated Polio Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Live Attenuated Polio Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Live Attenuated Polio Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Live Attenuated Polio Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Live Attenuated Polio Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Live Attenuated Polio Vaccine, Product Type & Application

2.7 Live Attenuated Polio Vaccine Market Competitive Situation and Trends

2.7.1 Live Attenuated Polio Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Live Attenuated Polio Vaccine Players Market Share by Revenue

2.7.3 Global Live Attenuated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Live Attenuated Polio Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Live Attenuated Polio Vaccine Global Live Attenuated Polio Vaccine Sales by Region: 2019-2030

3.2.1 Global Live Attenuated Polio Vaccine Sales by Region: 2019-2024

3.2.2 Global Live Attenuated Polio Vaccine Sales by Region: 2025-2030

3.3 Global Live Attenuated Polio Vaccine Global Live Attenuated Polio Vaccine Revenue by Region: 2019-2030

3.3.1 Global Live Attenuated Polio Vaccine Revenue by Region: 2019-2024

3.3.2 Global Live Attenuated Polio Vaccine Revenue by Region: 2025-2030

3.4 North America Live Attenuated Polio Vaccine Market Facts & Figures by Country

3.4.1 North America Live Attenuated Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Live Attenuated Polio Vaccine Sales by Country (2019-2030)

3.4.3 North America Live Attenuated Polio Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Live Attenuated Polio Vaccine Market Facts & Figures by Country

3.5.1 Europe Live Attenuated Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Live Attenuated Polio Vaccine Sales by Country (2019-2030)

3.5.3 Europe Live Attenuated Polio Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Live Attenuated Polio Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Live Attenuated Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Live Attenuated Polio Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Live Attenuated Polio Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Live Attenuated Polio Vaccine Market Facts & Figures by Country

3.7.1 Latin America Live Attenuated Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Live Attenuated Polio Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Live Attenuated Polio Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Live Attenuated Polio Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Live Attenuated Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Live Attenuated Polio Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Live Attenuated Polio Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Live Attenuated Polio Vaccine Sales by Type (2019-2030)

4.1.1 Global Live Attenuated Polio Vaccine Sales by Type (2019-2024)

4.1.2 Global Live Attenuated Polio Vaccine Sales by Type (2025-2030)

4.1.3 Global Live Attenuated Polio Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Live Attenuated Polio Vaccine Revenue by Type (2019-2030)

4.2.1 Global Live Attenuated Polio Vaccine Revenue by Type (2019-2024)

4.2.2 Global Live Attenuated Polio Vaccine Revenue by Type (2025-2030)

4.2.3 Global Live Attenuated Polio Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Live Attenuated Polio Vaccine Price by Type (2019-2030)

5.1 Global Live Attenuated Polio Vaccine Sales by Application (2019-2030)

5.1.1 Global Live Attenuated Polio Vaccine Sales by Application (2019-2024)

5.1.2 Global Live Attenuated Polio Vaccine Sales by Application (2025-2030)

5.1.3 Global Live Attenuated Polio Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Live Attenuated Polio Vaccine Revenue by Application (2019-2030)

5.2.1 Global Live Attenuated Polio Vaccine Revenue by Application (2019-2024)

5.2.2 Global Live Attenuated Polio Vaccine Revenue by Application (2025-2030)

5.2.3 Global Live Attenuated Polio Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Live Attenuated Polio Vaccine Price by Application (2019-2030)

6.1 Sanofi Pasteur

6.1.1 Sanofi Pasteur Corporation Information

6.1.2 Sanofi Pasteur Description and Business Overview

6.1.3 Sanofi Pasteur Live Attenuated Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Sanofi Pasteur Live Attenuated Polio Vaccine Product Portfolio

6.1.5 Sanofi Pasteur Recent Developments/Updates

6.2 GlaxoSmithKline Bio

6.2.1 GlaxoSmithKline Bio Corporation Information

6.2.2 GlaxoSmithKline Bio Description and Business Overview

6.2.3 GlaxoSmithKline Bio Live Attenuated Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GlaxoSmithKline Bio Live Attenuated Polio Vaccine Product Portfolio

6.2.5 GlaxoSmithKline Bio Recent Developments/Updates

6.3 Bilthoven Bio

6.3.1 Bilthoven Bio Corporation Information

6.3.2 Bilthoven Bio Description and Business Overview

6.3.3 Bilthoven Bio Live Attenuated Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Bilthoven Bio Live Attenuated Polio Vaccine Product Portfolio

6.3.5 Bilthoven Bio Recent Developments/Updates

6.4 Bharat Biotech

6.4.1 Bharat Biotech Corporation Information

6.4.2 Bharat Biotech Description and Business Overview

6.4.3 Bharat Biotech Live Attenuated Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bharat Biotech Live Attenuated Polio Vaccine Product Portfolio

6.4.5 Bharat Biotech Recent Developments/Updates

6.5 Sinovac Biotech

6.5.1 Sinovac Biotech Corporation Information

6.5.2 Sinovac Biotech Description and Business Overview

6.5.3 Sinovac Biotech Live Attenuated Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sinovac Biotech Live Attenuated Polio Vaccine Product Portfolio

6.5.5 Sinovac Biotech Recent Developments/Updates

7.1 Live Attenuated Polio Vaccine Industry Chain Analysis

7.2 Live Attenuated Polio Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Live Attenuated Polio Vaccine Production Mode & Process

7.4 Live Attenuated Polio Vaccine Sales and Marketing

7.4.1 Live Attenuated Polio Vaccine Sales Channels

7.4.2 Live Attenuated Polio Vaccine Distributors

7.5 Live Attenuated Polio Vaccine Customers

8.1 Live Attenuated Polio Vaccine Industry Trends

8.2 Live Attenuated Polio Vaccine Market Drivers

8.3 Live Attenuated Polio Vaccine Market Challenges

8.4 Live Attenuated Polio Vaccine Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Live Attenuated Polio Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

    Table 2. Global Live Attenuated Polio Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

    Table 3. Global Live Attenuated Polio Vaccine Market Competitive Situation by Manufacturers in 2023

    Table 4. Global Live Attenuated Polio Vaccine Sales (K Units) of Key Manufacturers (2019-2024)

    Table 5. Global Live Attenuated Polio Vaccine Sales Market Share by Manufacturers (2019-2024)

    Table 6. Global Live Attenuated Polio Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

    Table 7. Global Live Attenuated Polio Vaccine Revenue Share by Manufacturers (2019-2024)

    Table 8. Global Market Live Attenuated Polio Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)

    Table 9. Global Key Players of Live Attenuated Polio Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

    Table 10. Global Key Manufacturers of Live Attenuated Polio Vaccine, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Live Attenuated Polio Vaccine, Product Type & Application

    Table 12. Global Key Manufacturers of Live Attenuated Polio Vaccine, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Live Attenuated Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Polio Vaccine as of 2023)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Live Attenuated Polio Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 17. Global Live Attenuated Polio Vaccine Sales by Region (2019-2024) & (K Units)

    Table 18. Global Live Attenuated Polio Vaccine Sales Market Share by Region (2019-2024)

    Table 19. Global Live Attenuated Polio Vaccine Sales by Region (2025-2030) & (K Units)

    Table 20. Global Live Attenuated Polio Vaccine Sales Market Share by Region (2025-2030)

    Table 21. Global Live Attenuated Polio Vaccine Revenue by Region (2019-2024) & (US$ Million)

    Table 22. Global Live Attenuated Polio Vaccine Revenue Market Share by Region (2019-2024)

    Table 23. Global Live Attenuated Polio Vaccine Revenue by Region (2025-2030) & (US$ Million)

    Table 24. Global Live Attenuated Polio Vaccine Revenue Market Share by Region (2025-2030)

    Table 25. North America Live Attenuated Polio Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 26. North America Live Attenuated Polio Vaccine Sales by Country (2019-2024) & (K Units)

    Table 27. North America Live Attenuated Polio Vaccine Sales by Country (2025-2030) & (K Units)

    Table 28. North America Live Attenuated Polio Vaccine Revenue by Country (2019-2024) & (US$ Million)

    Table 29. North America Live Attenuated Polio Vaccine Revenue by Country (2025-2030) & (US$ Million)

    Table 30. Europe Live Attenuated Polio Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 31. Europe Live Attenuated Polio Vaccine Sales by Country (2019-2024) & (K Units)

    Table 32. Europe Live Attenuated Polio Vaccine Sales by Country (2025-2030) & (K Units)

    Table 33. Europe Live Attenuated Polio Vaccine Revenue by Country (2019-2024) & (US$ Million)

    Table 34. Europe Live Attenuated Polio Vaccine Revenue by Country (2025-2030) & (US$ Million)

    Table 35. Asia Pacific Live Attenuated Polio Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

    Table 36. Asia Pacific Live Attenuated Polio Vaccine Sales by Region (2019-2024) & (K Units)

    Table 37. Asia Pacific Live Attenuated Polio Vaccine Sales by Region (2025-2030) & (K Units)

    Table 38. Asia Pacific Live Attenuated Polio Vaccine Revenue by Region (2019-2024) & (US$ Million)

    Table 39. Asia Pacific Live Attenuated Polio Vaccine Revenue by Region (2025-2030) & (US$ Million)

    Table 40. Latin America Live Attenuated Polio Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 41. Latin America Live Attenuated Polio Vaccine Sales by Country (2019-2024) & (K Units)

    Table 42. Latin America Live Attenuated Polio Vaccine Sales by Country (2025-2030) & (K Units)

    Table 43. Latin America Live Attenuated Polio Vaccine Revenue by Country (2019-2024) & (US$ Million)

    Table 44. Latin America Live Attenuated Polio Vaccine Revenue by Country (2025-2030) & (US$ Million)

    Table 45. Middle East & Africa Live Attenuated Polio Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 46. Middle East & Africa Live Attenuated Polio Vaccine Sales by Country (2019-2024) & (K Units)

    Table 47. Middle East & Africa Live Attenuated Polio Vaccine Sales by Country (2025-2030) & (K Units)

    Table 48. Middle East & Africa Live Attenuated Polio Vaccine Revenue by Country (2019-2024) & (US$ Million)

    Table 49. Middle East & Africa Live Attenuated Polio Vaccine Revenue by Country (2025-2030) & (US$ Million)

    Table 50. Global Live Attenuated Polio Vaccine Sales (K Units) by Type (2019-2024)

    Table 51. Global Live Attenuated Polio Vaccine Sales (K Units) by Type (2025-2030)

    Table 52. Global Live Attenuated Polio Vaccine Sales Market Share by Type (2019-2024)

    Table 53. Global Live Attenuated Polio Vaccine Sales Market Share by Type (2025-2030)

    Table 54. Global Live Attenuated Polio Vaccine Revenue (US$ Million) by Type (2019-2024)

    Table 55. Global Live Attenuated Polio Vaccine Revenue (US$ Million) by Type (2025-2030)

    Table 56. Global Live Attenuated Polio Vaccine Revenue Market Share by Type (2019-2024)

    Table 57. Global Live Attenuated Polio Vaccine Revenue Market Share by Type (2025-2030)

    Table 58. Global Live Attenuated Polio Vaccine Price (US$/Unit) by Type (2019-2024)

    Table 59. Global Live Attenuated Polio Vaccine Price (US$/Unit) by Type (2025-2030)

    Table 60. Global Live Attenuated Polio Vaccine Sales (K Units) by Application (2019-2024)

    Table 61. Global Live Attenuated Polio Vaccine Sales (K Units) by Application (2025-2030)

    Table 62. Global Live Attenuated Polio Vaccine Sales Market Share by Application (2019-2024)

    Table 63. Global Live Attenuated Polio Vaccine Sales Market Share by Application (2025-2030)

    Table 64. Global Live Attenuated Polio Vaccine Revenue (US$ Million) by Application (2019-2024)

    Table 65. Global Live Attenuated Polio Vaccine Revenue (US$ Million) by Application (2025-2030)

    Table 66. Global Live Attenuated Polio Vaccine Revenue Market Share by Application (2019-2024)

    Table 67. Global Live Attenuated Polio Vaccine Revenue Market Share by Application (2025-2030)

    Table 68. Global Live Attenuated Polio Vaccine Price (US$/Unit) by Application (2019-2024)

    Table 69. Global Live Attenuated Polio Vaccine Price (US$/Unit) by Application (2025-2030)

    Table 70. Sanofi Pasteur Corporation Information

    Table 71. Sanofi Pasteur Description and Business Overview

    Table 72. Sanofi Pasteur Live Attenuated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 73. Sanofi Pasteur Live Attenuated Polio Vaccine Product

    Table 74. Sanofi Pasteur Recent Developments/Updates

    Table 75. GlaxoSmithKline Bio Corporation Information

    Table 76. GlaxoSmithKline Bio Description and Business Overview

    Table 77. GlaxoSmithKline Bio Live Attenuated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 78. GlaxoSmithKline Bio Live Attenuated Polio Vaccine Product

    Table 79. GlaxoSmithKline Bio Recent Developments/Updates

    Table 80. Bilthoven Bio Corporation Information

    Table 81. Bilthoven Bio Description and Business Overview

    Table 82. Bilthoven Bio Live Attenuated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 83. Bilthoven Bio Live Attenuated Polio Vaccine Product

    Table 84. Bilthoven Bio Recent Developments/Updates

    Table 85. Bharat Biotech Corporation Information

    Table 86. Bharat Biotech Description and Business Overview

    Table 87. Bharat Biotech Live Attenuated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 88. Bharat Biotech Live Attenuated Polio Vaccine Product

    Table 89. Bharat Biotech Recent Developments/Updates

    Table 90. Sinovac Biotech Corporation Information

    Table 91. Sinovac Biotech Description and Business Overview

    Table 92. Sinovac Biotech Live Attenuated Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 93. Sinovac Biotech Live Attenuated Polio Vaccine Product

    Table 94. Sinovac Biotech Recent Developments/Updates

    Table 95. Key Raw Materials Lists

    Table 96. Raw Materials Key Suppliers Lists

    Table 97. Live Attenuated Polio Vaccine Distributors List

    Table 98. Live Attenuated Polio Vaccine Customers List

    Table 99. Live Attenuated Polio Vaccine Market Trends

    Table 100. Live Attenuated Polio Vaccine Market Drivers

    Table 101. Live Attenuated Polio Vaccine Market Challenges

    Table 102. Live Attenuated Polio Vaccine Market Restraints

    Table 103. Research Programs/Design for This Report

    Table 104. Key Data Information from Secondary Sources

    Table 105. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Live Attenuated Polio Vaccine

    Figure 2. Global Live Attenuated Polio Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

    Figure 3. Global Live Attenuated Polio Vaccine Market Share by Type in 2023 & 2030

    Figure 4. Live Attenuated Vaccine Product Picture

    Figure 5. Inactivated Vaccine Product Picture

    Figure 6. Global Live Attenuated Polio Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

    Figure 7. Global Live Attenuated Polio Vaccine Market Share by Application in 2023 & 2030

    Figure 8. Hospital

    Figure 9. Clinic

    Figure 10. Health Center

    Figure 11. Others

    Figure 12. Global Live Attenuated Polio Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

    Figure 13. Global Live Attenuated Polio Vaccine Market Size (2019-2030) & (US$ Million)

    Figure 14. Global Live Attenuated Polio Vaccine Sales (2019-2030) & (K Units)

    Figure 15. Global Live Attenuated Polio Vaccine Average Price (US$/Unit) & (2019-2030)

    Figure 16. Live Attenuated Polio Vaccine Report Years Considered

    Figure 17. Live Attenuated Polio Vaccine Sales Share by Manufacturers in 2023

    Figure 18. Global Live Attenuated Polio Vaccine Revenue Share by Manufacturers in 2023

    Figure 19. The Global 5 and 10 Largest Live Attenuated Polio Vaccine Players: Market Share by Revenue in 2023

    Figure 20. Live Attenuated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

    Figure 21. Global Live Attenuated Polio Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Figure 22. North America Live Attenuated Polio Vaccine Sales Market Share by Country (2019-2030)

    Figure 23. North America Live Attenuated Polio Vaccine Revenue Market Share by Country (2019-2030)

    Figure 24. United States Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 25. Canada Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 26. Europe Live Attenuated Polio Vaccine Sales Market Share by Country (2019-2030)

    Figure 27. Europe Live Attenuated Polio Vaccine Revenue Market Share by Country (2019-2030)

    Figure 28. Germany Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 29. France Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 30. U.K. Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 31. Italy Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 32. Russia Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 33. Asia Pacific Live Attenuated Polio Vaccine Sales Market Share by Region (2019-2030)

    Figure 34. Asia Pacific Live Attenuated Polio Vaccine Revenue Market Share by Region (2019-2030)

    Figure 35. China Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 36. Japan Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 37. South Korea Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 38. India Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 39. Australia Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 40. China Taiwan Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 41. Southeast Asia Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 42. Latin America Live Attenuated Polio Vaccine Sales Market Share by Country (2019-2030)

    Figure 43. Latin America Live Attenuated Polio Vaccine Revenue Market Share by Country (2019-2030)

    Figure 44. Mexico Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 45. Brazil Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 46. Argentina Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 47. Middle East & Africa Live Attenuated Polio Vaccine Sales Market Share by Country (2019-2030)

    Figure 48. Middle East & Africa Live Attenuated Polio Vaccine Revenue Market Share by Country (2019-2030)

    Figure 49. Turkey Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 50. Saudi Arabia Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 51. UAE Live Attenuated Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 52. Global Sales Market Share of Live Attenuated Polio Vaccine by Type (2019-2030)

    Figure 53. Global Revenue Market Share of Live Attenuated Polio Vaccine by Type (2019-2030)

    Figure 54. Global Live Attenuated Polio Vaccine Price (US$/Unit) by Type (2019-2030)

    Figure 55. Global Sales Market Share of Live Attenuated Polio Vaccine by Application (2019-2030)

    Figure 56. Global Revenue Market Share of Live Attenuated Polio Vaccine by Application (2019-2030)

    Figure 57. Global Live Attenuated Polio Vaccine Price (US$/Unit) by Application (2019-2030)

    Figure 58. Live Attenuated Polio Vaccine Value Chain

    Figure 59. Live Attenuated Polio Vaccine Production Process

    Figure 60. Channels of Distribution (Direct Vs Distribution)

    Figure 61. Distributors Profiles

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed